Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
A Phase II Trial of SGI-110 in Patients With IPSS High and Int 2 Myelodysplastic Syndrome, Acute Myeloid Leukemia With 20-30% Marrow Blasts or Chronic Myelomonocytic Leukemia Type 2 Not Responding to
ClinicalTrials.gov study NCT02197676. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03125876. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Toxicity of Increasing Doses of Idarubicin, Cytarabine and G-CSF in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01700413. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06027853. IPD Sharing: NO. Countries: 1. Publications: 0.
Retrospective Analysis of the Outcome of Patients With Relapsed/Refractory Acute Myeloid Leukemia Included in a Patient Named Program of Gemtuzumab Ozogamicin/Mylotarg®
ClinicalTrials.gov study NCT03287128. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05519384. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Oral Venetoclax Tablets in Combination With Subcutaneously (SC) or Intravenously (IV) Inject
ClinicalTrials.gov study NCT05587049. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03181815. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations
ClinicalTrials.gov study NCT02298166. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04887857. IPD Sharing: YES. Countries: 2. Publications: 0.
Correlation of Venetoclax Plasma Concentrations With Toxicity of Hypometilating Agents and Venetoclax Combination for Acute Myeloid Leukemia Patients in Remission.
ClinicalTrials.gov study NCT07254312. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT03940352. IPD Sharing: NO. Countries: 7. Publications: 0.
S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00066794. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00077116. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02856204. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy
ClinicalTrials.gov study NCT06643962. IPD Sharing: NO. Countries: 1. Publications: 0.
Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant
ClinicalTrials.gov study NCT02485535. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cilengitide in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00089388. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00053144. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02198482. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.